Successful Treatment of a Fibromyalgia Patient Using a Homeopathic Preparation of Cannabis sativa

Abstract

Background Homeopathy has been used in observational and controlled studies to treat patients with fibromyalgia (FM), but none has previously used the remedy Cannabis sativa.

Case History A 51-year-old female patient presenting with diffuse pain and sleep disorder was diagnosed with FM using the relevant American College of Rheumatology criteria. She reported having 18 tender points, a pain score (visual analog scale, VAS) of 9.0, and a well-being VAS of 5.0. She was prescribed Cannabis sativa 6 cH, five drops sublingually thrice a day.

Results After 2 months, she returned asymptomatic, with 0 tender points, pain VAS of 0, and well-being VAS of 9.0. The Modified Naranjo Criteria for Homeopathy score was equal to +9, suggesting the clinical outcome was causally attributable to the medicine prescribed.

Conclusion This case study reveals the positive role of homeopathic treatment in FM. Studies using a randomized controlled design, including pragmatic trials to determine treatment effectiveness in real-world clinical practice, are indicated in this field.

Keywords

cannabis - fibromyalgia - chronic condition - homeopathy

Publikationsverlauf

Eingereicht: 12. Mai 2023

Angenommen: 13. Juli 2023

Artikel online veröffentlicht:
30. Oktober 2023

• References

• 1 Ruschak I, Montesó-Curto P, Rosselló L, Martín CA, Sánchez-Montesó L, Toussaint L. Fibromyalgia syndrome pain in men and women: a scoping review. Healthcare (Basel) 2023; 11: 223
• 2 Nishishinya B, Urrútia G, Walitt B. et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford) 2008; 47: 1741-1746
• 3 Crofford LJ, Appleton BE. Complementary and alternative therapies for fibromyalgia. Curr Rheumatol Rep 2001; 3: 147-156
• 4 Dimmock S, Troughton PR, Bird HA. Factors predisposing to the resort of complementary therapies in patients with fibromyalgia. Clin Rheumatol 1996; 15: 478-482
• 5 Thompson EA, Mathie RT, Baitson ES. et al. Towards standard setting for patient-reported outcomes in the NHS homeopathic hospitals. Homeopathy 2008; 97: 114-121
• 6 Boehm K, Raak C, Cramer H, Lauche R, Ostermann T. Homeopathy in the treatment of fibromyalgia—a comprehensive literature review and meta-analysis. Complement Ther Med 2014; 22: 731-742
• 7 Khurshid H, Qureshi IA, Jahan N. et al. A systematic review of fibromyalgia and recent advancements in treatment: is medicinal cannabis a new hope?. Cureus 2021; 13: e17332
• 8 van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
• 9 Wolfe F, Clauw DJ, Fitzcharles MA. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62: 600-610
• 10 Lamba CD, Gupta VK, van Haselen R. et al. Evaluation of the Modified Naranjo Criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109: 191-197
• 11 Katz-Talmor D, Katz I, Porat-Katz BS, Shoenfeld Y. Cannabinoids for the treatment of rheumatic diseases—where do we stand?. Nat Rev Rheumatol 2018; 14: 488-498
• 12 Sukul NC, Bala SK, Bhattacharyya B. Prolonged cataleptogenic effects of potentized homoeopathic drugs. Psychopharmacology (Berl) 1986; 89: 338-339
• 13 Naudé DF, Couchman IMS, Maharaj A. Chronic primary insomnia: efficacy of homeopathic simillimum. Homeopathy 2010; 99: 63-68
• 14 Homeopathy Pharmacopoeia of India. Combined Volume I to V (revised and augmented). New Delhi: Govt. of India, Ministry of Health and Family Welfare; 2016. : 151 & 40
• 15 Boericke W. Pocket Manual of Homoeopathic Materia Medica. Indian ed. Calcutta: Sett Dey; 1976: 160